Bayer Introduces Versatile New Option for Heartworm Prevention and Intestinal Parasite Control
Coraxis™ (moxidectin) Topical Solution for Dogs provides veterinarians with 30-day heartworm protection and treats and controls hookworms, roundworms and whipworms
Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs. The product is expected to be available for sale in early February.
“Coraxis™ is a unique addition to the veterinarian’s anti-parasite toolbox,” said Robert Zolynas, DVM, MBA, Head of Research and Development North America for Bayer Animal Health. “Its transdermal formulation is rapidly absorbed, achieving and sustaining high plasma levels of moxidectin to continuously kill incoming heartworm larvae for thirty days. This important feature along with its broad-spectrum intestinal worm protection, make it a versatile and useful product.”
Administered monthly, Coraxis™ is a prescription drug that should be administered on the order of a veterinarian. It provides veterinarians more flexibility in creating parasite protection plans for dogs. Coraxis™ is available in five different sizes and is for use in dogs and puppies 7 weeks of age and older weighing between 3 to 110 pounds.
Short URL: https://caninechronicle.com/?p=157521
Posted by chesliepickett
on Jan 21 2019. Filed under Health & Training.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
Comments are closed
